Recent publications on Cancer

Lange JM, Gard CC, O'Meara ES, Miglioretti DL, Etzioni R. Breast density and risk of breast cancer: Masking and detection bias. Am J Epidemiol. 2024 Aug 3:kwae245. doi: 10.1093/aje/kwae245. [Epub ahead of print]. PubMed

Sprague BL, Ichikawa L, Eavey J, Lowry KP, Rauscher GH, O'Meara ES, Miglioretti DL, Lee JM, Stout NK, Herschorn SD, Perry H, Weaver DL, Kerlikowske K. Performance of supplemental US screening in women with dense breasts and varying breast cancer risk: Results from the Breast Cancer Surveillance Consortium. Radiology. 2024 Aug;312(2):e232380. doi: 10.1148/radiol.232380. PubMed

Briggs ES, Thomas RM, Frost MC, Fletcher OV, Crothers K, Chalal CK, Shahrir SF, McClure JB, Catz SL, Williams EC. "I thought cancer was a tobacco issue": Perspectives of veterans with and without HIV on cancer and other health risks associated with alcohol and tobacco/nicotine use. AIDS Behav. 2024;28(8):2607-2618. doi: 10.1007/s10461-024-04363-6. Epub 2024 Jun 13. PubMed

Murphy NR, Crothers K, Snidarich M, Budak JZ, Brown MC, Weiner BJ, Giustini N, Caverly T, Durette K, DeCell K, Triplette M. A tailored decision aid improves understanding of lung cancer screening in people with HIV. Chest. 2024 Jul 29:S0012-3692(24)04876-1. doi: 10.1016/j.chest.2024.07.147. [Epub ahead of print]. PubMed

Dang TH, Rieu-Werden ML, Kobrin SC, Tiro JA, Werner C, Lykken JM, Chubak J, Atlas SJ, Higashi RT, Lee SC, Haas JS, Skinner CS, Silver MI, Feldman S. Association between clinician confidence and making guideline-recommended decisions in the management of abnormal cervical cancer screening results. J Gen Intern Med. 2024 Jul 25. doi: 10.1007/s11606-024-08943-z. [Epub ahead of print]. PubMed

Bhimani J, O’Connell K, Persaud S, Blinder V, Burganowski R, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED. Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer. Cancer Epidemiol Biomarkers Prev. 2024 Jul 25. doi: 10.1158/1055-9965.EPI-24-0360. Online ahead of print. PubMed

White LL, Sawyer JK, Zepp JM, Prado YK, Reyes AA, Maiyani M, Shuster E, Zucker R, Henrikson NB, Rope AF, Weinmann S, Feigelson HS, Ezzell Hunter J. Genetic testing uptake among ovarian cancer survivors in the Genetic Risk Analysis in Ovarian Cancer (GRACE) study. Cancers (Basel). 2024;16(14):2563. doi: 10.3390/cancers16142563.  PubMed

Bhimani J, O’Connell K, Persaud S, Blinder V, Burganowski R, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Rivera DR, Roh JM, Tabatabai S, Valice E, Bandera EV, Bowles EJA, Kushi LH, Kantor ED. Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer. Int J Cancer. 2024 Jul 6. doi: 10.1002/ijc.35053. Online ahead of print. PubMed

Lee JM, Ichikawa LE, Kerlikowske K, Buist DSM, Lee CI, Sprague BL, Henderson LM, Onega T, Wernli KJ, Lowry KP, Stout NK, Tosteson ANA, Miglioretti DL. Relative timing of mammography and MRI for breast cancer screening: Impact on performance evaluation. J Am Coll Radiol. 2024 Jul 3:S1546-1440(24)00597-0. doi: 10.1016/j.jacr.2024.06.020. Online ahead of print. PubMed

Boratyn VM, Pocobelli G, Atlas SJ, Clark CR, Feldman S, Kruse G, Marie McCarthy A, Rieu-Werden M, Silver MI, Santini NO, Tiro JA, Haas JS. Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systems.  Prev Med Rep. 2024 Jun 1;43:102783. doi: 10.1016/j.pmedr.2024.102783. eCollection 2024. PubMed

Petrik AF, Rivelli JS, Firemark AJ, Johnson CA, Locher BW, Gille S, Najarian MJ, Varga AM, Schneider JL, Green B, Winer RL. A qualitative assessment of the acceptability of human papillomavirus self-sampling and informational materials among diverse populations.  Cancer Med. 2024;13(14):e70033. doi: 10.1002/cam4.70033.  PubMed

Bhimani J, O'Connell K, Ergas IJ, Foley M, Gallagher GB, Griggs JJ, Heon N, Kolevska T, Kotsurovskyy Y, Kroenke CH, Laurent CA, Liu R, Nakata KG, Persaud S, Rivera DR, Roh JM, Tabatabai S, Valice E, Bowles EJA, Bandera EV, Kushi LH, Kantor ED. Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019.  Breast Cancer Res. 2024;26(1):101. doi: 10.1186/s13058-024-01822-9.  PubMed

Hahn EE, Munoz-Plaza CE, Jensen CD, Ghai NR, Pak K, Amundsen BI, Contreras R, Cannizzaro N, Chubak J, Green BB, Skinner CS, Halm EA, Schottinger JE, Levin TR. Patterns of care following a positive fecal blood test for colorectal cancer: A mixed methods study. J Gen Intern Med. 2024 May 21. doi: 10.1007/s11606-024-08764-0. [Epub ahead of print]. PubMed

Vo JB, Ramin C, Veiga LHS, Brandt C, Curtis RE, Bodelon C, Barac A, Roger VL, Feigelson HS, Buist DSM, Bowles EJA, Gierach GL, Berrington de González A. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in U.S. breast cancer survivors. J Natl Cancer Inst. 2024 May 8:djae107. doi: 10.1093/jnci/djae107. [Epub ahead of print]. PubMed

Carter-Bawa L, Slaven JE Jr, Monahan PO, Brandzel S, Gao H, Wernli KJ, Lafata JE, Rawl SM. Unpacking the relationship between shared decision-making and decisional quality, decision to screen, and screening completion in lung cancer screening.  Patient Educ Couns. 2024;122:108143. doi: 10.1016/j.pec.2024.108143. Epub 2024 Jan 11.  PubMed

Mehta SJ, Palat S, McDonald C, Reitz C, Okorie E, Williams K, Tao J, Shaw PA, Glanz K, Asch DA. A randomized trial of choice architecture and mailed colorectal cancer screening outreach in a community health setting. Clin Gastroenterol Hepatol. 2024 Apr 30:S1542-3565(24)00390-2. doi: 10.1016/j.cgh.2024.04.003. [Epub ahead of print]. PubMed

Trentham-Dietz A, Chapman CH, Jayasekera J, Lowry KP, Heckman-Stoddard BM, Hampton JM, Caswell-Jin JL, Gangnon RE, Lu Y, Huang H, Stein S, Sun L, Gil Quessep EJ, Yang Y, Lu Y, Song J, Muñoz DF, Li Y, Kurian AW, Kerlikowske K, O'Meara ES, Sprague BL, Tosteson ANA, Feuer EJ, Berry D, Plevritis SK, Huang X, de Koning HJ, van Ravesteyn NT, Lee SJ, Alagoz O, Schechter CB, Stout NK, Miglioretti DL, Mandelblatt JS. Collaborative modeling to compare different breast cancer screening strategies: A decision analysis for the US Preventive Services Task Force. JAMA. 2024;331(22):1947-60. Epub 20240430. doi: 10.1001/jama.2023.24766. PubMed

Smith RE, Sprague BL, Henderson LM, Kerlikowske K, Miglioretti DL, Wernli KJ, Onega T, diFlorio-Alexander RM, Tosteson ANA. Breast density knowledge and willingness to delay treatment for pre-operative breast cancer imaging among women with a personal history of breast cancer.  Breast Cancer Res. 2024;26(1):73. doi: 10.1186/s13058-024-01820-x.  PubMed

Wernli KJ, Haupt EC, Chawla N, Osuji T, Shen E, Smitherman AB, Casperson M, Kirchhoff AC, Zebrack BJ, Keegan THM, Kushi L, Baggett C, Kaddas HK, Ruddy KJ, Sauder CAM, Wun T, Figueroa Gray M, Chubak J, Nichols H, Hahn EE. Emergency department use in adolescent and young adult cancer early survivors from 2006 to 2020. J Adolesc Young Adult Oncol. 2024 Apr 29. doi: 10.1089/jayao.2023.0174 [Epub ahead of print] PubMed

Haas CB, Chen H, Harrison T, Fan S, Gago-Dominguez M, Castelao JE, Bolla MK, Wang Q, Dennis J, Michailidou K, Dunning AM, Easton DF, Antoniou AC, Hall P, Czene K, Andrulis IL, Mulligan AM, Milne RL, Fasching PA, Haeberle L, Garcia-Closas M, Ahearn T, Gierach GL, Haiman C, Maskarinec G, Couch FJ, Olson JE, John EM, Chenevix-Trench G, de Gonzalez AB, Jones M, Stone J, Murphy R, Aronson KJ, Wernli KJ, Hsu L, Vachon C, Tamimi RM, Lindström S. Disentangling the relationships of body mass index and circulating sex hormone concentrations in mammographic density using Mendelian randomization. Breast Cancer Res Treat. 2024 Apr 24. doi: 10.1007/s10549-024-07306-w. Online ahead of print. PubMed